Peter Lindborg
Corporate Officer/Principal presso Biogen International GmbH
Provenienza dei contatti di primo grado di Peter Lindborg
Entità | Tipo di entità | Settore Industriale | |
---|---|---|---|
7
| Public Company | Pharmaceuticals: Major | 7 |
Biogen International GmbH
Biogen International GmbH Pharmaceuticals: MajorHealth Technology Biogen International GmbH produces pharmaceuticals. It develops medicines for psoriasis and multiple sclerosis. Its products include FUMADERM and BG-12. The company was founded in 1983 and is headquartered in Lucerne, Switzerland.
1
| Subsidiary | Pharmaceuticals: Major | 1 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Peter Lindborg tramite i suoi contatti personali
Società | Settore | Persone collegate | Posizione principale |
---|---|---|---|
TENGION, INC. | Biotechnology | Corporate Officer/Principal | |
BeneChill, Inc.
BeneChill, Inc. Medical SpecialtiesHealth Technology BeneChill, Inc. develops non-invasive cooling technology for cerebral ischemia treatment. The company was founded by Michael L. Berman and Denise Barbut in 2004 is headquartered in San Diego, CA. | Medical Specialties | Director/Board Member | |
Arctic Funds Plc - Aurora LifeScience | Investment Trusts/Mutual Funds | Corporate Officer/Principal | |
HealthCap AB
HealthCap AB Investment ManagersFinance HealthCap AB (HealthCap) is a venture capital subsidiary of Odlander, Fredrikson & Co. AB founded in 1995 by Björn Ingemar Odlander and Peder Fredrikson. The firm is headquartered in Stockholm, Sweden with an additional office in Switzerland. | Investment Managers | Private Equity Investor | |
Perbio Science AB
Perbio Science AB BiotechnologyHealth Technology Perbio Science AB develops and manufactures products and equipment for the scientific research and biopharmaceutical industries. It carries out operations through three divisions: Bioresearch, Cell Culture, and Medical Device. The company also offers voice rehabilitation services and treatment for menorrhagia. It has offices in Sweden, Belgium, China, New Zealand, the United Kingdom, and the United States. Perbio Science is headquartered in Helsingborg, Sweden. | Biotechnology | Director of Finance/CFO | |
NTG NORDIC TRANSPORT GROUP A/S | Trucking | Director/Board Member | |
Odlander, Fredrikson & Co. AB
Odlander, Fredrikson & Co. AB Financial ConglomeratesFinance Odlander Fredrikson & Co. AB provides financial support services. The company was founded in 1996 and is headquartered in Stockholm, Sweden. | Financial Conglomerates | Corporate Officer/Principal | |
AstraZeneca AB
AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
ALK-ABELLÓ A/S | Biotechnology | Chief Tech/Sci/R&D Officer | |
Karolinska Institutet | College/University | Doctorate Degree | |
SEB Venture Capital
SEB Venture Capital Investment ManagersFinance SEB Venture Capital (SEB Venture Capital) is a venture capital subsidiary of Skandinaviska Enskilda Banken AB founded in 1995. The firm is headquartered in Stockholm, Sweden. | Investment Managers | Corporate Officer/Principal | |
Newron Sweden AB
Newron Sweden AB Pharmaceuticals: MajorHealth Technology Newron Sweden AB is a biopharmaceutical company engaged in the development of novel therapies for the treatment of disorders of the central nervous systems. The company was founded by Jonas Cristopher Frisen and Ann Marie Janson in 1998 and is headquartered in Stockholm, Sweden. | Pharmaceuticals: Major | Chairman | |
ONCOPEPTIDES AB | Pharmaceuticals: Major | Director/Board Member | |
NEXSTIM PLC | Medical Specialties | Director/Board Member | |
TopoTarget UK Ltd.
TopoTarget UK Ltd. Drugstore ChainsRetail Trade TopoTarget UK Ltd. engages in the discovery and development of drugs and therapies to treat cancer. It develops anti-cancer drugs for molecular mechanisms associated with the cell cycle, chromatin control and DNA damage. The company was founded in 2002 and is headquartered in Oxford, the United Kingdom. | Drugstore Chains | Director/Board Member | |
ABIONYX PHARMA | Pharmaceuticals: Major | Director/Board Member | |
Cerenis Therapeutics, Inc.
Cerenis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Cerenis Therapeutics, Inc. discovers, develops and commercializes drugs for the treatment of cardiovascular and metabolic diseases. It focuses on discovery, development, and commercialization of HDL therapies. Cerenis Therapeutics is located in Ann Arbor, MI. | Pharmaceuticals: Major | Director/Board Member | |
Aprea Therapeutics AB
Aprea Therapeutics AB Pharmaceuticals: MajorHealth Technology Aprea Therapeutics AB operates as a holding company that provides research performed at Karolinska Institutet. It focuses its activities on discovery and development of novel anticancer compounds targeting the tumor suppressor protein. Its product has been tested in a Phase I/II dose escalating safety study in patients with refractory hematological malignancies or prostate carcinoma. It pursues the development of an anticancer drug, APR-246, which has p53-based mechanism for patients with ovarian cancer. The company was founded by Klas Gosta Wiman, Galina Selivanova, Vladimir Bykov, Wenjie Bao, Natalia Issaeva, and Staffan Strömblad in 2003 and is headquartered in Solna, Sweden. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Pergamum AB
Pergamum AB Pharmaceuticals: MajorHealth Technology Pergamum AB develops, registers, markets, and trades pharmaceutical products based on therapeutic peptides. The company was founded on June 18, 2008 and is headquartered in Solna, Sweden. | Pharmaceuticals: Major | Chairman | |
Healthcap 1999 GP AB
Healthcap 1999 GP AB Investment Banks/BrokersFinance Part of Odlander, Fredrikson & Co. AB, Healthcap 1999 GP AB is a company that manages and trades securities. The company is based in Stockholm, Sweden. | Investment Banks/Brokers | Director/Board Member | |
Targovax Oy
Targovax Oy Pharmaceuticals: MajorHealth Technology Targovax Oy focuses on the development and commercialization of targeted cancer immunotherapy. It is a biotechnology company with novel immunotherapy platform that is based on engineered oncolytic viruses armed with potent immune-stimulating transgenes. The firm's products induce a tailored response by the immune system directed at each patient’s unique cancer cells. The company was founded by Pekka Ilmari Simula and Antti Vuolanto in 2009 and is headquartered in Helsinki, Finland. | Pharmaceuticals: Major | Director/Board Member | |
NEOS AB | Medical Specialties | Chairman | |
KAROLINSKA DEVELOPMENT AB | Financial Conglomerates | Chief Executive Officer | |
Palette Life Sciences AB
Palette Life Sciences AB Medical SpecialtiesHealth Technology Palette Life Sciences AB operates as a pharmaceutical company. It specializes in developing products for local pain relief in obstetrics and gynecology. The company was founded by Berith Karlsson Tingåker, Gunvor Ekman-Ordeberg, Arne Folke Brodin and Lars Irestedt in 2009 and is headquartered in Solna, Sweden. | Medical Specialties | Director/Board Member | |
Aprea Personal AB | Chairman | ||
Axela AB | Director/Board Member | ||
CIRCIO HOLDING ASA | Biotechnology | Director/Board Member | |
KDev Investments AB
KDev Investments AB BiotechnologyHealth Technology KDev Investments AB engages in research, sales, and development in the fields of medicine, biotechnology, pharmaceuticals, and medical technology. It also owns and manages investments of companies in the fields of medicine. Its portfolio will include both early and clinical stage pharmaceutical assets, as well as some technology assets. The company was founded on January 10, 2012 and is headquartered in Solna, Sweden. | Biotechnology | Director/Board Member | |
Trimb Healthcare AB
Trimb Healthcare AB Pharmaceuticals: MajorHealth Technology Trimb Healthcare AB operates as a over the counter pharmaceutical company. It focuses on sales, marketing and development of prescription free pharmaceuticals, and consumer healthcare products. The company was founded by Mikael Pålsson in 2012 and is headquartered in Stockholm, Sweden. | Pharmaceuticals: Major | Director/Board Member | |
SYNACT PHARMA AB | Pharmaceuticals: Major | Chief Executive Officer | |
Ancilla AB
Ancilla AB Real Estate DevelopmentFinance Ancilla AB manages real properties. The company is headquartered in Stockholm, Sweden. | Real Estate Development | Director/Board Member | |
Glionova AB
Glionova AB Pharmaceuticals: MajorHealth Technology Glionova AB develops cancer treatment drugs. The firm is a drug discovery and development company. It offers GLN-1001 product. The company was founded by Lars G. J. Hammarström and Patrik Ernfors in 2014 and is headquartered in Stockholm, Sweden. | Pharmaceuticals: Major | Director/Board Member | |
Arctic Asset Management AS (Sweden)
Arctic Asset Management AS (Sweden) Investment ManagersFinance Arctic Asset Management AS (Sweden) (AAM-Sweden) is the Sweden-based investment management arm of Arctic Asset Management AS, ultimately owned by Arctic Securities AS in Norway. The firm was founded in 2016 and is headquartered in Stockholm. AFM-Sweden manages portfolio of Nordic equities, Nordic fixed income and Global Life Science – through mutual funds and discretionary mandates for institutional clients, family offices, investment companies and private clients. | Investment Managers | Founder | |
Healthcap Aero Holdings Gp | Director/Board Member | ||
Healthcap Orx Holdings Gp AB
Healthcap Orx Holdings Gp AB Investment Banks/BrokersFinance Healthcap Orx Holdings Gp AB is a private company that manages securities. The company is based in Stockholm, Sweden. | Investment Banks/Brokers | Director/Board Member | |
Trimb Holding AB
Trimb Holding AB Financial ConglomeratesFinance Part of Karo Healthcare AB, Trimb Holding AB operates as a holding Swedish company with interest in pharmaceuticals. The company is based in Stockholm, Sweden. | Financial Conglomerates | Director/Board Member | |
Vivet Therapeutics SAS
Vivet Therapeutics SAS BiotechnologyHealth Technology Vivet Therapeutics SAS develops novel gene therapy treatments for inherited metabolic diseases. The firm offers its services under the categorizers of Biopharma, Biotechnology and Health Care. The company was founded by Jean-Philippe Combal, Gloria Gonzalez-Aseguinolaza and Jens Kurth on July 26, 2016 and is headquartered in Paris, France. | Biotechnology | Director/Board Member | |
Biothea Pharma, Inc.
Biothea Pharma, Inc. Miscellaneous Commercial ServicesCommercial Services Biothea Pharma, Inc. is an American biotechnology company that operates in the field of pharmaceuticals. The private company was founded by John F. Vavricka. Marina S. Bozilenko has been the CEO of the company since 2021. | Miscellaneous Commercial Services | Director/Board Member | |
Momentum Energy Hanstholm K/S
Momentum Energy Hanstholm K/S Electric UtilitiesUtilities Momentum Energy Hanstholm K/S is a leading asset manager that specializes in managing solar and wind projects throughout their entire life cycle. Momentum Energy Hanstholm is based in Copenhagen, DK, and the CEO of the private company is Michael Shalmi. The Danish company's main focus is to maximize the return on their customers' green assets within the wind and solar energy sector. The company manages all processes in the operational phase and assist in the sale and sourcing of solar plants and wind farms. | Electric Utilities | Chief Executive Officer | |
Momentum Energy Jutlandia P/S
Momentum Energy Jutlandia P/S Alternative Power GenerationUtilities Momentum Energy Jutlandia P/S is a holding Danish company that operates wind turbines through its subsidiaries. The private company is based in Copenhagen, Denmark and has subsidiaries in Denmark. The CEO of the company is Michael Shalmi. | Alternative Power Generation | Chief Executive Officer | |
Momentum Energy Jutlandia Development K/S
Momentum Energy Jutlandia Development K/S Alternative Power GenerationUtilities Part of Momentum Energy Jutlandia P/S, Momentum Energy Jutlandia Development K/S generates wind electricity. The company is based in Copenhagen, Denmark. The CEO of the Danish company is Michael Shalmi. | Alternative Power Generation | Chief Executive Officer | |
TXP Pharma AG (Switzerland)
TXP Pharma AG (Switzerland) Pharmaceuticals: MajorHealth Technology Part of SynAct Pharma AB, TXP Pharma AG (Switzerland) engages in researching and developing pharmaceutical drugs for the treatment of autoimmune and inflammatory diseases. The company is based in Baar, Switzerland. TXP Pharma AG (Switzerland was acquired by SynAct Pharma AB from GoodWind Holding GmbH on January 16, 2023 for $264.94 million. | Pharmaceuticals: Major | Chairman | |
Momentum Energy Group A/S
Momentum Energy Group A/S Electric UtilitiesUtilities Momentum Energy Group A/S is a holding Danish company that provides electricity production services. The private company is based in Roskilde, Denmark and has subsidiaries in Denmark. The CEO of the company is Michael Shalmi. | Electric Utilities | Chief Executive Officer | |
Curexsys AG | Chairman | ||
TXP Pharma GmbH | Founder |
Statistiche
Distribuzione geografica
Svezia | 29 |
Danimarca | 7 |
Stati Uniti | 5 |
Francia | 4 |
Finlandia | 3 |
Settori
Health Technology | 25 |
Finance | 11 |
Utilities | 5 |
Commercial Services | 3 |
Miscellaneous | 2 |
Posizioni
Director/Board Member | 106 |
Chairman | 42 |
Chief Executive Officer | 19 |
Independent Dir/Board Member | 18 |
Corporate Officer/Principal | 16 |
Contatti più connessi
- Borsa valori
- Insiders
- Peter Lindborg
- Connessioni Società